You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Quinlan Paul T · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$1.12M
Quinlan Paul T General Counsel
ORKA
Oruka Therapeutics
ORKA
Transaction date
Aug 14, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$111.04
Aug 14, 2026
First close after public filing
$112.66
Aug 17, 2026
30-day return after filing
-14.85%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,434 shares @ $107.14
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000077
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.24M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 14, 2026 | $78K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 14, 2026 | $1.59M |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 14, 2026 | $1.11M |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 14, 2026 | $525K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 14, 2026 | $1.01M |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 14, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Aug 14, 2026 | $1.12M |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 14, 2026 | $384.96K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 14, 2026 | $427.55K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 14, 2026 | $0 |